Jeremy T. Grant

Insider Reports History

Entity
Individual
Location
C/O Olshan Frome Wolosky Llp, 1325 Avenue Of The Americas, New York, NY
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeremy T. Grant:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Theravance Biopharma, Inc. Director Ordinary Shares 22.3K $193K $8.64 May 8, 2024 Direct
Theravance Biopharma, Inc. Director Share Option (Right to Buy) 23.6K May 8, 2024 Direct

Insider Reports Filed by Jeremy T. Grant

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TBPH Theravance Biopharma, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
TBPH Theravance Biopharma, Inc. Dec 21, 2023 4 $0 4 Dec 26, 2023 Director
TBPH Theravance Biopharma, Inc. Dec 21, 2023 0 $0 3 Dec 26, 2023 Director